Endocannabinoids tonically suppressed cardiac contractility in hypertension and could normalize blood pressure by enhancing the CB1R-mediated cardiopressor and vasodilator effects of endogenous AEA (151). The gene discussed is CNR1; the disease is hypertensive disorder.